Brain And Neuroimaging Devices Market Report 2026

Brain And Neuroimaging Devices Market Overview

• Brain And Neuroimaging Devices market size has reached to $44.1 billion in 2025 • Expected to grow to $59.26 billion in 2030 at a compound annual growth rate (CAGR) of 6.1% • Growth Driver: Rising Prevalence Of Traumatic Brain Injuries In Brain And Neuroimaging Devices Market • Market Trend: Technology Advancements With Artificial Intelligence (AI) In Brain And Neuroimaging Device Market • Western Europe was the largest region in 2025 and North America is the fastest growing region.

What Is Covered Under Brain And Neuroimaging Devices Market?

Brain and neuroimaging devices are medical devices used to capture the structure, function, or pharmacology of the brain and locate areas affected by neurological disorders. They are used to study cognitive processes and diagnose neurological conditions. The main imaging types of brain and neuroimaging devices are functional magnetic resonance imaging (fMRI), computed tomography (CT), positron emission tomography (PET), electroencephalography (EEG), magnetoencephalography (MEG), and others. Positron emission tomography (PET) is a type of imaging technique that measures the metabolic activity of the cells of body tissues using radioactive substances. The various applications of brain and neuroimaging devices are Parkinson's disease, traumatic brain injury, epilepsy, dementia, sleep disorders, and other applications that are used in hospitals, diagnostic centers, and ambulatory surgical centers.

What Is The Brain And Neuroimaging Devices Market Growth Forecast?

The brain and neuroimaging devices market size is expected to see strong growth in the next few years. It will grow to $59.26 billion in 2030 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to increasing demand for early detection of brain disorders, expansion of precision neurology applications, growing investments in neuroimaging research, rising adoption of hybrid imaging systems, increasing integration of imaging with digital health platforms. Major trends in the forecast period include increasing adoption of ai-assisted neuroimaging analysis, rising use of high-resolution brain imaging modalities, growing integration of multimodal imaging techniques, expansion of functional brain mapping applications, enhanced focus on early neurological diagnosis.

Global Brain And Neuroimaging Devices Market Segmentation

1) By Imaging Type: Functional Magnetic Resonance Imaging (FMRI), Computed Tomography (CT), Positron Emission Tomography (PET), Electroencephalography (EEG), Magneto Encephalography (MEG), Other Imaging Types 2) By Application: Parkinson’s Disease, Traumatic Brain Injury, Epilepsy, Dementia, Sleep Disorders, Other Applications 3) By End-User: Hospitals, Diagnostic Centres, Research Institutes And Neurology Clinics Subsegments: 1) By Functional Magnetic Resonance Imaging (FMRI): Resting-State FMRI, Task-Based FMRI, Diffusion Tensor Imaging (DTI) With FMRI 2) By Computed Tomography (CT): X-ray CT, Positron Emission Tomography (PET) Or CT Hybrid Imaging, Multi-Slice CT 3) By Positron Emission Tomography (PET): PET Or CT, PET Or MRI 4) By Electroencephalography (EEG): Conventional EEG, Ambulatory EEG, High-Density EEG 5) By Magnetoencephalography (MEG): Whole-Head MEG, Electromagnetic Source Imaging (ESI) With MEG 6) By Other Imaging Types: Near-Infrared Spectroscopy (NIRS), Transcranial Magnetic Stimulation (TMS), Functional Near-Infrared Brain Imaging Systems

What Are The Drivers Of The Brain And Neuroimaging Devices Market?

The rising prevalence of traumatic brain injuries is anticipated to propel the growth of brain and neuroimaging devices market going forward. Traumatic brain injury (TBI) refers to an injury or damage to the brain that occurs as a result of a sudden, external force or trauma that has effects on an individual's physical, cognitive, emotional, and behavioural functioning. Brain and neuroimaging devices are used in the diagnosis, assessment, and management of traumatic brain injury (TBI) and help doctors identify any bleeding, fractures, or structural abnormalities. For instance, in October 2023, according to the Neural Regeneration Research, a China-based peer-reviewed academic journal that focuses on neuroscience, particularly in the areas of neural regeneration, neuroprotection, each year, approximately 69 million people are suffering from traumatic brain injury (TBI). Therefore, the rising prevalence of traumatic brain injuries is driving the growth of the brain and neuroimaging device industry. The rising healthcare expenditure is expected to propel the growth of the brain and neuroimaging devices market going forward. Healthcare expenditure refers to the total amount of financial resources spent on healthcare services, including medical treatments, hospital care, medications, and public health initiatives, by governments, businesses, and individuals. The increasing demand for healthcare expenditure is due to the rising prevalence of chronic diseases, which require long-term and costly treatments. Rising healthcare expenditure enhances brain and neuroimaging devices by enabling greater investment in advanced diagnostic technologies and expanding access to specialized imaging services. It supports improved infrastructure, early disease detection, and better patient outcomes, driving wider adoption of high-precision neuroimaging solutions. For instance, in May 2024, according to the Office for National Statistics, a UK-based government department, total healthcare expenditure saw a 5.6% increase in nominal terms in 2023, an increase of 0.9% growth compared to 2022. Therefore, the rising healthcare expenditure is driving the growth of the brain and neuroimaging devices industry

Key Players In The Global Brain And Neuroimaging Devices Market

Major companies operating in the brain and neuroimaging devices market are GE HealthCare, Siemens AG, Koninklijke Philips, Canon Medical Systems Corporation, Hitachi Medical Systems, EB Neuro S.p.A., Neurosoft, MinFound Medical Systems Co. Ltd., Elekta, Toshiba Corporation, Shimadzu Corporation, Bruker Corporation, PerkinElmer Inc., Carl Zeiss Meditec AG, Fujifilm Holdings Corporation, Nihon Kohden Corporation, Natus Medical Incorporated, RIMED Ltd., Advanced Brain Monitoring Inc., Compumedics Limited

Global Brain And Neuroimaging Devices Market Trends and Insights

Major companies operating in the brain and neuroimaging device market are focusing on the development of technology with artificial intelligence (AI), such as Neuro Suite, to gain a competitive edge in the market. Neuro Suite with artificial intelligence is designed to provide comprehensive solutions as a brain and neuroimaging device for neurological disorders. For Instance, in April 2023, TeraRecon, Inc., a US-based company that develops medical imaging equipment, launched the Neuro Suite. Neuro Suite is an artificial intelligence (AI)-assisted clinical suite solution for neurology diseases such as neuro-oncology, multiple sclerosis, and dementia. This allows radiologists to access a variety of artificial intelligence (AI)-powered neuroimaging modalities.

Regional Outlook

Western Europe was the largest region in the brain and neuroimaging devices market in 2025. North America was the second-largest region in the global brain and neuroimaging devices market report. Africa. was the smallest region in the brain and neuroimaging devices market. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.

What Defines the Brain And Neuroimaging Devices Market?

The brain and neuroimaging devices market consists of sales of imaging equipment for brain and nerves such as functional magnetic resonance imaging, computed tomography, positron emission tomography (pet), electroencephalography, magnetoencephalography, and others. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.